Skip to main content
. 2019 Apr 2;11(4):464. doi: 10.3390/cancers11040464

Figure 1.

Figure 1

Patient CONSORT diagram. Poly-ICLC, polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose; BEV, bevacizumab.